Jyothy Labs Joint Md On Coronavirus, Business Strategy, Outlook

Jyothy Labs Joint MD on Coronavirus, Business Strategy, Outlook

Bloomberg Television

Jyothy Labs On 2019 Outlook #BQ

Mr Ullas Kamath, Joint Managing Director, Jyothy Labs Ltd in conversation with Ms Hiral Dadia Desai.

STREET SIGNS: K Ullas Kamath Jt MD & CFO, Jyothy Laboratories- March 05

Jyothy Laboratories: Comfortable With Current Pricing Levels

Mr. Ullas Kamath, Joint MD, Jyothy Labs Ltd In Conversation With Ms. Hiral Dadia

Jyothy Labs' MD On September Quarter Performance

Will be interested to sell stake to Henkel: Jyothy Lab

NDTV

MD Of Jyothy Labs On Product Portfolio, Vision For 2030 & More | MR Jyothy EXCLUSIVE | N18V

The Vision Ahead For Jyothy Labs, Navigating Competition & Acquisition Plans: MD MR Jyothy Exclusive

IT- Dept probes Jyothy Labs’ offices and plant #shortsvideo

Jyothy Labs Earnings Call for Q3FY21

Talking Point With Jyothy Labs' K Ullas Kamath

Expect To Grow By 10-12% In Terms Of Volume In FY18: Jyothy Labs

IT- Dept probes Jyothy Labs’ offices and plant #shorts

VARINDIA FACEOFF

Earnings Edge- Jyothy Labs Posts Bright Q1

Bloomberg TV India

Mr. Ullas Kamath, Joint MD, Jyothy Labs Limited In Conversation With Ms. Hiral Dadia

Tax Cuts Enough To Tackle Slowdown? | K Ullas Kamath of Jyothy Labs To ET NOW

Jyothy Labs On The Company's Key Growth Drivers And More

#Q1WithBQ: Decoding Jyothy Laboratories' Earnings